In vivo and in vitro treatments were carried out to investigate the effects of a 95% ethanol extract of Chroogomphus rutilus (CRE) on antioxidant, hypoglycemic, hypolipidemic, and antitumor properties. CRE showed potent radical scavenging activity against DPPH in vitro. It could increase antioxidant enzymatic activities (superoxide dismutase and glutathione peroxidase) and could reduce malondialdehyde content in vivo in mice in which aging was induced by d-galactose. CRE had hypoglycemic activity and could significantly inhibit α-glucosidase activity in vitro and decrease blood glucose concentration in vivo. CRE could decrease the serum total cholesterol, triglyceride, and low-density lipoprotein cholesterol levels and increase the high-density lipoprotein cholesterol level in diabetic mice. The MTT assay showed that CRE also had a certain inhibitory effect on the tumor cells. These results suggest that CRE may be beneficial for human health and could be useful for applications in medicine, the food industry, and agriculture.
I. INTRODUCTION
Mushrooms have been used for many years, not only as a nutritious food but also for various health reasons. Mushrooms have a very long tradition of use in Asian countries because of their bioactivities such as anticancer, antioxidant, immunomodulating, antiviral, antimicrobial, antiaging, antidiabetic, and hypoglycemic activities. [1] [2] [3] [4] The activity of ethanol extracts from mushrooms have also been widely studied. An ethanol extract from Ramaria flava possesses DPPH free radical scavenging and anti-lipid peroxidation qualities. 2 An ethanol extract of Agaricus bisporus has antioxidant activity. 3 And an ethanol extract of Antrodia cinnamomea reduces the proliferation and migration of WEHI-3 cells. 4 The brown slimecap mushroom, Chroogomphus rutilus (Schaeff.) O.K. Mill. (= Gomphidius rutilans; Gomphidiaceae, Agaricomycetes) is a species of edible mushroom with some bioactivity. It is an important wild edible mushroom in North China. Crude polysaccharides from Ch. rutilus have protective effects on dopaminergic neurons impaired by MPP(+). 5 An ethanol extract of Ch. rutilus was reported to have good antioxidant properties, to have nitrite scavenging effects, and to inhibit nitrosamine formation. 6, 7 The aim of this study was to evaluate the antioxidant, hypoglycemic, hypolipidemic, and antitumor bioactivities of a 95% ethanol extract of Ch. rutilus (CRE) to evaluate its healthful properties.
II. MATERIALS AND METHODS

A. Mushroom Material and Animals
Ch. rutilus fruiting bodies were manually collected from Yanshan Mountain in Hebei Province and were identified by Prof. Li-An Wang (Life Science College, Hebei Normal University). The fresh fruiting bodies were dried in a drying box at a constant temperature (42°C) until the weight did not change; then they were preserved at the applied mycology laboratory of Hebei Normal University.
Male Kunming mice (weight, 18-22 g) were purchased from the Laboratory Animal Center of Hebei Medical University. Animal experiments were conducted under principles of good laboratory animal care and approved by the Ethical Committee for Laboratory Animals Care and Use of Hebei Normal University (registration no. 147008).
B. Preparation of CRE
The fresh fruiting bodies were dried in a drying box at a constant temperature (42°C) until the weight did not change, then powered in a grinder. Powder of dried Ch. rutilus fruiting bodies (500 g) was stirred using 5 L 95% ethanol for 2 hours and left to stand overnight at 4°C. The filtrate was concentrated under a vacuum at 45°C to yield the 95% ethanol extract (CRE). To get more of the 95% ethanol extract, the remaining precipitate was extracted again (3-5 times) following the protocol described above. The CRE was combined and then weighed to measure the extraction yield; the yield of ethanol extract from Ch. rutilus was 32.43%.
C. DPPH Radical Scavenging Activity
All reactions were conducted in 96-well microplates according to the method described by Bondet et al., 8 with some modifications. The CRE was redissolved in methanol. CRE (100 μL) at defined concentrations was mixed with 100 μL (2 × 10 −4 mol · L −1 ) DPPH solution. Vitamin C (Vc), which has a strong ability to clear DPPH free radicals, was used as a standard reference. In addition, 100 μL CRE at defined concentrations was mixed with 100 μL ethanol, and these samples were used as blanks. Finally, 100 μL methanol and 100 μL (2 × 10 −4 mol · L −1
) DPPH solution were mixed, and this sample was used as the control. After 30 minutes of incubation at ambient temperature in darkness, the absorbance at 517 nm was determined with a spectrophotometer. Each experiment was repeated 6 times with the same extract sample.
Scavenging activity was calculated according to the following formula:
where A sample is the absorbance of CRE or Vc mixed with DPPH at a particular concentration. A blank and A control are the absorbances of the blank and control samples, respectively. The half-maximal effective concentration (EC 50 ) was determined with SPSS 1.0 software.
D. Measurements of Glutathione Peroxidase, Superoxide Dismutase, and Malondialdehyde
The antioxidant effect of the CRE on tissue oxidative markers was studied based on the following method, 9,10 with some modifications. The mice were divided into 6 groups (n = 6 mice/group): blank group (group 1), model group (group 2), standard control group (group 3), low-dose group (group 4), medium-dose group (group 5), and high-dose group (group 6). Group 1 was injected with physiological saline only, whereas the other groups were injected with d-galactose at 300 mg · kg
. The stomachs of the mice in groups 1 and 2 were gavaged with equal amounts of distilled water. The stomachs of the mice in group 3 were gavaged with 100 mg Vc · kg −1 · d −1 (Vc was used as the standard reference). The stomachs of the mice in groups 4, 5, and 6 were gavaged with CRE at concentrations of 100, 200, and 400 mg · kg
, which was dissolved in distilled water. The stomach of every mouse was gavaged with the specified agent every day for 4 weeks.
Antioxidant enzyme activities and lipid hydroperoxide malondialdehyde (MDA) in the serum and livers of mice in all groups were assayed using commercial kits: a glutathione peroxidase (GSH-Px) assay kit for GSH-Px activity, a total superoxide dismutase (SOD) assay kit for SOD activity, and an MDA assay kit to determine the concentration of MDA. All kits were pursued from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
E. α-Glucosidase Inhibition Activity
The α-glucosidase inhibition activity was determined according to the method described by Chapdelaine et al. 11 A total of 1 mL CRE at the defined concentrations and 500 μL phosphate buffer (67 mmol · L , and the absorbance was read at 405 nm and compared with that of a negative control that had 1 mL buffer solution in place of the extract. A defined concentration of acarbose was used as the standard control. The α-glucosidase inhibition activity was calculated according to the following formula:
where A sample is the absorbance of CRE or acarbose added at a particular concentration, A blank is the absorbance of the CRE or acarbose alone, and A control is the absorbance of the negative control mentioned above.
F. Preparation of the Diabetic Mouse Model
In the experiment, a total of 50 Kunming mice were acclimatized to standard husbandry conditions for 3 days. Then, 6 mice were randomly selected for inclusion in the blank group (group 1) and were fed a normal pellet diet until the end of the experiment. The rest of the mice were fed a pellet diet high in fat and sugar (HFD) for 4 weeks. The HFD comprised 66.5% powdered normal pellet diet, 20% sucrose, 10% lard oil, 2.5% cholesterol, and 1% sodium cholate. The mice fed the HFD were also injected with streptozotocin (STZ), which was dissolved in citric acid buffer (120 mg · kg −1 ; pH 4.4), whereas the mice in group 1 received the same volume of citric acid buffer (pH 4.4). After the STZ injection (72 hours), the mice with nonfasting blood glucose concentrations >16.8 mmol · L −1 were randomly divided into 5 groups with 6 mice in each group. Group 2 served as the model group and the mice were treated with the same volume of distilled water. The group 3 mice served as the standard control, and their stomachs were gavaged with 150 mg metformin hydrochloride · kg −1 · d −1 . The mice in groups 4, 5, and 6 served as the lowdose, medium-dose, high-dose groups, respectively, and their stomachs were gavaged with CRE at the defined concentrations dissolved in distilled water. Each group had their stomachs gavaged and continued with their respective diets throughout the experimental period. 12, 13 
G. Measurement of Blood Glucose Concentrations
Blood glucose meters (ACCU-CHECK Active; Roche, Berlin, Germany) were used to assess blood from the tail vein of fasted diabetic mice, according to the manufacturer's instructions. Values were measured every week for 4 weeks.
H. Measurements of Triglycerides, Total
Cholesterol, High-Density Lipoprotein Cholesterol, and Low-Density Lipoprotein Cholesterol
After 4 weeks, the animals in each group were deeply anesthetized by intraperitoneal injection of sodium pentobarbital, and blood was subsequently collected from the eye for plasma analysis. Plasma was analyzed for triglycerides (TGs), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) according to the kit instructions (Nanjing Jiancheng Bioengineering Institute).
I. MTT Cell Viability Assay
An MTT assay was performed according to the method described by Wang et al. 14 Each test was repeated at least 6 times. The concentration required to inhibit viability by 50% was determined with SPSS 1.0 software.
J. Data Analysis
The data were analyzed using 1-way analysis of variance with STATISTICA 6.0 software; P < 0.05 was considered to represent statistical significance. All experiments were repeated at least 3 times, and the data are presented as means ± standard deviations.
III. RESULTS
A. Antioxidant Activity In Vitro and In Vivo
The scavenging activity of the CRE tested was compared with that of Vc, which was used as the standard control (Table 1 ). In general, CRE reduced the radical concentration in a dose-dependent manner. The EC 50 of CRE was 1.19 mg · mL −1 . Although its free radical scavenging ability was not stronger than that of Vc at the same concentration, when the CRE reached 8 mg · mL −1 , 93.73% inhibition of DPPH radicals was obtained.
We also tested the antioxidant activity of CRE in serum and liver (Tables 2 and 3 ). Table 2 shows the effect of CRE on the serum GSH-Px, total SOD, and MDA concentrations in mice in which aging was induced by d-galactose.
After the mice were treated with d-galactose, as shown in Table 2 , the MDA concentration increased and GSH-Px and SOD activities were significantly lower in the model group than those in the normal group (P < 0.05). After the aging mice were fed CRE, both GSH-Px and total SOD enzyme activity increased in a dose-dependent manner, and the level of MDA decreased. Increases in serum GSH-Px and total SOD and the decrease in MDA levels were significant (P < 0.05) in groups 5 and 6 compared with in group 2.
The effects of CRE on liver GSH-Px, total SOD, and MDA concentrations in mice in which aging was induced by d-galactose were also tested. As shown in Table 3 , the antioxidant activity of CRE in liver was similar to that in serum. The results of this study indicate that CRE could increase the activity of SOD and GSH-Px, decrease the concentration of MDA, and consequently increase the antioxidant activities of the serum and liver.
B. α-Glucosidase Inhibitory Activity
The hypoglycemic effect of CRE was evaluated in vitro. CRE exhibited potent inhibitory activity against α-glucosidase in a dose-dependent manner (Fig. 1) . The EC 50 of CRE was 1.62 mg · mL −1 . Although the inhibition rate of CRE was lower than that of clinically used acarbose, CRE had a marked inhibitory effect against α-glucosidase, with a maximum inhibition rate of 92.3% when its concentration reached 10 mg · mL −1 .
C. Antidiabetic Effect in Diabetic Mice
The hypoglycemic effect of CRE was evaluated in STZ-induced diabetic mice fed the HFD. CRE was intragastrically administered to the diabetic mice at doses of 100, 200, and 400 mg · kg −1 · d −1 to evaluate its hypoglycemic effect. As shown in Table 4 , blood glucose concentrations significantly decreased (P < 0.01 or P < 0.05) after dosing with CRE for 14 days. Blood glucose concentrations also significantly decreased (P < 0.01) in groups 4, 5, and 6 compared with group 2 after 21 and 28 days of treatment. The hypoglycemic effect in groups 4, 5, and 6 was almost the same; thus, the dose of CRE did not have an extensive hypoglycemic effect. CRE at 400 mg · kg −1 · d −1 decreased blood glucose to 10.61 ± 0.73 mmol · L −1 after the mice were gavaged with CRE for 28 days; this concentration was statistically significantly lower than that in group 2 (20.91 ± 1.34 mmol · L −1 ), and the blood glucose concentration was decreased to 10.53 ± 0.72 mmol · L −1 in the standard control group (group 3). These results suggest that CRE can greatly decrease blood glucose concentration.
D. Hypolipidemic Effect in Diabetic Mice
The hypolipidemic effect of CRE was also evaluated in the STZ-induced diabetic mice that were fed the HFD. As shown in Table 5 , CRE decreased TG, TC, and LDL-C levels and increased the serum HDL-C level in a dose-dependent manner. In addition, the CRE fraction possessed significant lipid-lowering activity, as shown by an increase in the HDL-Cto-TC ratio (P < 0.01) in groups 4, 5, and 6 compared with that in group 2. Different concentrations of CRE could all increase the HDL-C level more than the standard control (metformin hydrochloride). The TG level in group 6 was decreased to 0.79 ± 0.04 mmol · L ). Although CRE was not better Data are mean ± standard deviation (n = 6). CRE, Ch. rutilus 95% ethanol extract. *P < 0.05 compared with the model group. **P < 0.01 compared with the model group.
# P < 0.05 compared with before dosing. ## P < 0.01 compared with before dosing. than the standard control for the other lipid-lowering indicators, the CRE fraction possessed significant lipid-lowering activity.
E. Inhibitory Effect of CRE on Tumor Cell Proliferation
The effects of CRE on the growth of 5 human tumor cell lines (K562, H446, SMMC-7721, MCF-7, and BGC-823) were tested by the MTT method. As shown in Table 6 , with increasing treatment concentrations, the inhibition effect of CRE on tumor cell proliferation in the different cell lines increased in a dose-dependent manner. BGC-823 was most sensitive to CRE; the half-maximal inhibitory concentration was 256.91 μg · mL −1
.
IV. DISCUSSION
Mushrooms are a component of the human diet, and they are popular in different parts of the world for their nutritional and therapeutic properties. Mushrooms with special flavors are nutritional foods because they are rich in carbohydrates, proteins, free amino acids, vitamins, minerals, and trace elements. They also contain bioactive metabolites such as lectins, polysaccharides, phenolics, and polyphenolics. Mushrooms have been reported to be associated with many potential health benefits, such as immunomodulatory, antiviral, antitumor, antibacterial, and antioxidant activities. 1, [15] [16] [17] [18] [19] [20] The beneficial properties of dietary mushrooms need to be investigated extensively in line with their health care-related properties. Ch. rutilus was reported to have good antioxidant properties, to have nitrite scavenging effects, and to inhibit nitrosamine formation 5 ; however, little is known about its other healthful properties. Therefore we investigated the potential antioxidant, hypoglycemic, hypolipidemic, and antitumor properties of CRE.
CRE had antioxidant activities both in vitro and in vivo. CRE reduced the radical concentration in a dose-dependent manner in vitro. CRE could increase the activity of SOD and GSH-Px, decrease the concentration of MDA, and consequently increase the antioxidant activities in the serum and liver in mice in which aging was induced by d-galactose. The scavenging abilities of 100% ethanol extracts on DPPH radicals have been reported as 86.85-90.54% at 2-4 mg · mL −1 . 6 The antioxidant components may be more easily dissolved in 100% ethanol than in 95% ethanol.
The mouse model of diabetes induced by an HFD and low-dose STZ reveals metabolic characteristics similar to those occurring in type 2 diabetes in humans. 21 In our study, such a model was applied to evaluate the hypoglycemic and hypolipidemic effects of CRE in vivo. During the experiment, we used different doses in different groups and found that the high dose was better than the other two doses, except for the hypoglycemic effect; the hypoglycemic effects of the doses in groups 4, 5, and 6 were almost the same. CRE can greatly decrease blood glucose concentrations in diabetic mice. Data are mean ± standard deviation (n = 6). CRE, Ch. rutilus 95% ethanol extract; IC 50 , half-maximal inhibitory concentration.
Serum lipids are usually elevated in diabetes mellitus, which is a risk factor for coronary heart disease. 22 We found that blood lipid concentrations were elevated in diabetic mice, and different degrees of lesions appeared in the livers, kidneys, and pancreases of diabetic mice. After treating the diabetic mice with CRE, the serum TC, TG, and LDL-C levels were significantly decreased; the HDL-C level and HDL-C-to-TC ratio increased significantly.
Several chemical compounds were isolated from the fruiting bodies of Ch. rutilus, and some research has revealed cytotoxicity against HSC-T6, SK-Hep1, and A549 cell lines. 23 Based on the results of our study, CRE has an inhibitory effect on the proliferation of other tumor cells (K562, H446, SMMC-7721, MCF-7, and BGC-823).
CRE exhibits potential antioxidant, hypoglycemic, hypolipidemic, and antitumor properties. The mechanisms of action of its compounds are worthy of further research. We have purified and identified some natural molecules from CRE to determine whether they have biological activity in order to illustrate how CRE works. We will also test whether the chemical compounds isolated by Luo et al. 23 have biological activity. The results presented here will promote the use of CRE in medicine, the food industry, and agriculture.
